Cancer Immunotherapy Blossoms Are Starting to Bear Fruit
Researchers are making progress in cancer immunotherapy by focusing on T cell activation and overcoming T cell exhaustion. New strategies, including vaccine therapies, aim to generate more efficient T cells to combat tumors.
Why it matters
Advancements in immunotherapy represent a major shift in cancer treatment, moving toward more personalized and effective biological interventions.
Over the last decade, there has been unprecedented success and progress in immunotherapy for cancer treatment, so says Ira Mellman, PhD, the president of research at the Parker Institute for Cancer Immunotherapy during his opening keynote at the Frontiers in Cancer Immunotherapy Symposium hosted by The New York Academy of Sciences, held on June 23, 2026.
The article provides a technical overview of medical symposium findings without ideological bias.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in